Management of Critically Ill Persons with COVID-19 and Diabetes

Medicine & Life Sciences

• Diabetic Ketoacidosis 100%
• Critical Illness 72%
• Insulin 53%
• Hyperglycemic Hyperosmolar Nonketotic Coma 32%
• Short-Acting Insulin 28%
• Personal Protective Equipment 27%
• Severe Acute Respiratory Syndrome 25%
• Coronavirus 24%
• Patient Acceptance of Health Care 23%
• Adult Respiratory Distress Syndrome 21%
• Pandemics 20%
• Electrolytes 18%
• Standard of Care 18%
• Acute Kidney Injury 18%
• Intensive Care Units 16%
• Emergencies 15%
• Occupational Groups 13%
• Glucose 12%
• Safety 11%